英特格拉生命科学 IART 深 沪
等待开盘 09-17 09:30:00 美东时间
14.89
-0.180
-1.19%
华盛通- 最 高15.11
- 今 开15.08
- 成交量 24.86万股
- 最 低 14.80
- 昨 收 15.07
- 总市值 11.60亿
- 52周最高 27.13
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 11.06
- 委 比 -88.68%
- 总股本 7791.08万
- 历史最高 77.40
- 量 比 0.41
- 振 幅 2.06%
- 历史最低 8.36
- 每 手 1
- 风险率 4.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多天星医疗冲击IPO，专注于运动医学器械领域，曾遭保荐人“抛弃”
在百济神州、恒瑞医药、和铂医药、圣诺医药等创新药个股不断向上打出高度的同时，不少医疗器械公司股价也在逐步攀升，包括微创医疗、春立医疗、微创机器人、赛诺医疗等。...
09-03 17:50
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Integra LifeSciences Holdings Corporation announced that its CEO Mojdeh Poul and CFO Lea Knight will present at two upcoming healthcare conferences: the Wells Fargo Healthcare Conference on September 3, 2025, and the Morgan Stanley Healthcare Conference on September 10, 2025. A live webcast of the presentations will be available on the company's investor relations website.
08-29 20:30
Bharti Airtel’s AGM Approves Key Resolutions to Strengthen Operations
The latest announcement is out from Bharti Airtel Limited ( ($IN:BHARTIARTL) )....
08-09 05:16
Integra Lifesciences (IART) Gets a Sell from Citi
Citi analyst maintained a Sell rating on Integra Lifesciences today. The compan...
08-01 19:18
Integra LifeSciences shares are trading higher after the company reported better-than-expected Q2 financial results,
Integra LifeSciences shares are trading higher after the company reported bette...
07-31 20:52
Integra Lifesciences Affirms FY2025 Adj EPS Guidance of $2.19-$2.29 vs $2.24 Est; Narrows FY2025 Sales Guidance from $1.650B-$1.715B to $1.655B-$1.680B vs $1.667B Est
Integra Lifesciences (NASDAQ:IART) affirms FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.29 vs $2.24 analyst estimate. Narrows FY2025 sales outlook from $1.650 billion-$1.715 billion to $1.655 billion-$1.680
07-31 18:08
Integra Lifesciences Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $415.605M Beat $395.067M Estimate
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.17 percent. This is a 28.57 percent decrease over earnings of $0.63 per share from
07-31 18:04
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
FDA Announces Applicator Recall: Integra LifeSciences Removes MicroMyst Applicators Due To Potential Sterility Concerns
https://www.fda.gov/medical-devices/medical-device-recalls/applicator-recall-integra-lifesciences-removes-micromyst-applicators-due-potential-sterility#:~:text=Reason%20for%20Recall,the%20products%20were%20effectively%20
07-21 23:26
英特尔(INTC.US)、特斯拉(TSLA.US)领衔！小摩披露下半年美股最佳做空名单
摩根大通美股分析师团队近日发表研报，筛选出了今年下半年“最具吸引力的结构性及战术性做空标的”。
07-15 15:14
